In this issue:
Cancer risk after RAI for hyperthyroidism
Statins for Graves’ orbitopathy
Thyroid lobectomy for paediatric T1 papillary thyroid carcinoma
Association of hypothyroidism and clinical depression
COVID-19 clinical outcomes in patients with prior thyroid cancer
Cost-effectiveness of primary aldosteronism screening in China
Lenvatinib for RAI-refractory thyroid carcinoma
Postoperative zoledronic acid for osteoporosis in primary hyperparathyroidism
Subacute thyroiditis following SARS-CoV- 2 vaccination
Managing adrenal insufficiency during the COVID-19 pandemic
Male fertility after RAI for differentiated thyroid carcinoma
How age and sex relate to Graves’ disease severity and prognosis
Please login below to download this issue (PDF)